A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

The Trump administration has cut around 100 employees, or roughly 10%, of the federal agency that oversees mental and ...

This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

JOHANNESBURG, Feb 18 (Reuters) - South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order ...